A novel nomogram to predict the local tumor progression after microwave ablation in patients with early‐stage hepatocellular carcinoma: A tool in prediction of successful ablation
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2606
Abstract: To develop a nomogram for the local tumor progression (LTP) in patients with early‐stage hepatocellular carcinoma (HCC) after computed tomography‐guided percutaneous microwave ablation (CT‐PMWA) and to assess clinical‐pathologic risk factors for individual LTP estimation. Furthermore,… read more here.
Keywords: tumor progression; patients early; ablation; early stage ... See more keywords
Serum Immune Biomarker Levels combined with Hepatitis B Virus Infection Status Predicts Early Recurrence of Early-Stage Hepatocellular Carcinoma with Microvascular Invasion after Liver Resection.
Sign Up to like & getrecommendations! Published in 2022 at "Acta chirurgica Belgica"
DOI: 10.1080/00015458.2022.2136051
Abstract: INTRODUCTION The tumor immune response plays a vital role in cancer recurrence in patients with malignancies. We aim to clarify the risk factors for early recurrence and investigate the efficacy of blood-based biomarkers to predict… read more here.
Keywords: early stage; recurrence early; stage hepatocellular; recurrence ... See more keywords
Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Hyperthermia"
DOI: 10.1080/02656736.2020.1752400
Abstract: Abstract Purpose To compared the benefits of sorafenib with microwave ablation (MWA) in intermediate-stage hepatocellular carcinoma (HCC) patients with tumor size ≤7 cm and tumor number ≤5 after Transcatheter Arterial Chemoembolization (TACE) failure. Methods A retrospective,… read more here.
Keywords: hepatocellular carcinoma; analysis; stage; intermediate stage ... See more keywords
A new ALBI‐based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Liver International"
DOI: 10.1111/liv.14194
Abstract: Transarterial chemoembolization (TACE) is a standard treatment for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma (HCC), but the outcome varied. This study aimed to develop a model to predict the outcome of TACE… read more here.
Keywords: hepatocellular carcinoma; model predict; transarterial chemoembolization; bclc stage ... See more keywords
Clinical values of Barcelona Clinic Liver Cancer subgroup and up-to-7 criteria in intermediate stage hepatocellular carcinoma with transcatheter arterial chemoembolization
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v10.i21.7275
Abstract: BACKGROUND Transarterial chemoembolization (TACE) is a recommended treatment for patients with intermediate stage hepatocellular carcinoma (HCC) but with variable treatment outcomes. AIM To determine factors for predicting outcomes of TACE in patients with intermediate stage… read more here.
Keywords: hepatocellular carcinoma; intermediate stage; tace; stage hepatocellular ... See more keywords
Exosomal miRNA in early-stage hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2023 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v11.i3.528
Abstract: The incidence and mortality of hepatic carcinoma (HCC) remain high, and early diagnosis of HCC is seen as a key approach in improving clinical outcomes. However, the sensitivity and specificity of current early screening methods… read more here.
Keywords: hepatocellular carcinoma; early stage; exosomal mirna; stage hepatocellular ... See more keywords
Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
Sign Up to like & getrecommendations! Published in 2019 at "Clinical and Molecular Hepatology"
DOI: 10.3350/cmh.2019.0010
Abstract: Very early stage hepatocellular carcinoma (HCC) is defined as a single tumor with the largest diameter of the lesion measuring 2 cm or less according to Barcelona Liver Cancer staging system. Detection of very early… read more here.
Keywords: hepatocellular carcinoma; hcc; detect early; early stage ... See more keywords
A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.608260
Abstract: Objective We sought to develop and validate a novel prognostic model for predicting survival of patients with Barcelona Clinic Liver Cancer Stages (BCLC) stage B hepatocellular carcinoma (HCC) using a machine learning approach based on… read more here.
Keywords: hepatocellular carcinoma; bclc stage; model; stage hepatocellular ... See more keywords
Transarterial Chemoembolization Combined With Tyrosine Kinase Inhibitors for Intermediate‐Stage Hepatocellular Carcinoma, What Else Can We Do?
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.824799
Abstract: Transarterial chemoembolization (TACE) has been considered the standard treatment for intermediate-stage hepatocellular carcinoma (HCC). However, intermediate‐stage HCC is highly heterogeneous with a broad population with varying tumour burdens, liver function. This suggests that TACE monotherapy… read more here.
Keywords: hepatocellular carcinoma; transarterial chemoembolization; intermediate stage; stage hepatocellular ... See more keywords
US-guided percutanous microwave ablation for early-stage hepatocellular carcinoma in elderly patients is as effective as in younger patients: A 10-year experience
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cancer Research and Therapeutics"
DOI: 10.4103/jcrt.jcrt_1021_19
Abstract: Objective: To compare the overall survival (OS), disease-free survival (DFS) and liver-cancer-specific survival (LCSS) of elderly (≥65 years) and younger patients (< 65 years) with early-stage hepatocellular carcinoma (HCC) using ultrasound-guided percutaneous microwave ablation (US-PMMA).… read more here.
Keywords: younger patients; ablation; elderly patients; early stage ... See more keywords